Eisai Pharmatechnology and Manufacturing India Private Ltd, a Japanese group company is planning to commence commercial operations of its Visakhapatnam unit by Sept 2010. The company had invested around Rs. 2500 million which had come up in Pharma Special City SEZ. The facility comprises of pilot plant, active pharmaceutical ingredients (API) unit, formulations manufacturing unit and a research lab. The unit will have a capacity of 2 billion tablet per year and 30 tonne of formulations. Its capacity may be doubled later.